TAE684

Target: This ligand targets anaplastic lymphoma kinase (ALK) in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for anaplastic lymphoma kinase (ALK). In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings anaplastic lymphoma kinase (ALK) into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC-Mediated EGFR Degradation: TAE684 can serve as a high-affinity EGFR-binding ligand within PROTAC constructs to drive ubiquitination and proteasome-dependent removal of EGFR. This enables systematic evaluation of degradation potency versus inhibition, including mapping degradation kinetics, dose–response behavior, and dependence on E3 ligase recruitment.

• E3 Ligase Recruitment Optimization: Incorporate TAE684 into PROTAC designs with alternative E3 ligase binders to tune ternary complex formation and ubiquitin transfer efficiency. Researchers can compare ligase-specific degradation profiles, optimize linker length and composition, and assess how these variables affect EGFR turnover, subcellular localization, and pathway rewiring.

• Resistance Mechanism Dissection: Use TAE684-based PROTACs to probe how EGFR degradation performs under resistance-associated contexts, such as altered EGFR conformations or signaling feedback. By contrasting degradation-driven signaling suppression with inhibitor-only approaches, experiments can identify whether proteolysis circumvents resistance and which molecular determinants govern residual activity.

• Targeted Signaling Pathway Mapping: Deploy TAE684-containing PROTACs to degrade EGFR and quantify downstream effects on MAPK/PI3K signaling, receptor trafficking, and compensatory receptor crosstalk. This supports mechanistic studies of how selective depletion reshapes phosphorylation networks and transcriptional programs compared with transient kinase blockade.

TAE684 is an ALK-oriented kinase ligand that can guide ALK-targeted degrader design. Linker placement should preserve the aminopyrimidine kinase-binding core and exploit solvent-exposed peripheral vectors.

Structure: TAE684 is an ALK-oriented kinase ligand containing an aminopyrimidine core, methoxy aryl substitution, a sulfonylated arylamino region, and a morpholine-containing side chain. The molecule presents multiple heteroatoms, aromatic recognition elements, and a basic tertiary amine.

Reactivity: For PROTAC development, the morpholine or peripheral aryl-sulfonyl side-chain vectors are preferable for linker installation, while the aminopyrimidine kinase-binding core should be preserved. Alkyl, PEG, amide, sulfonamide, or carbamate linkers may be connected to CRBN, VHL, or IAP ligands through linker-ready analogs. Each exit vector should be validated because changes near the hinge-binding heteroaryl region can compromise kinase engagement.